Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiping Tang

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 11, 2018
Acute Respiratory Distress Syndrome Induced by White Smoke Inhalation: a Potential Animal Model For Evaluating Pathological Changes and Underlying MechanismsPei Cui, Xiaoyan Feng, Feng Zhu, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 23, 2022
In Situ Silver-Based Electrochemical Oncolytic BioreactorYong Huang, Liping Zhong, Xiaotong Li, et al.
Cell|January 18, 2025
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patientsLiping Zhong, Lu Gan, Bing Wang, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 11, 2018
Acute Respiratory Distress Syndrome Induced by White Smoke Inhalation: a Potential Animal Model For Evaluating Pathological Changes and Underlying MechanismsPei Cui, Xiaoyan Feng, Feng Zhu, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 23, 2022
In Situ Silver-Based Electrochemical Oncolytic BioreactorYong Huang, Liping Zhong, Xiaotong Li, et al.
Cell|January 18, 2025
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patientsLiping Zhong, Lu Gan, Bing Wang, et al.
Pageof 3